Humoral Immune Response in Hematooncological Patients and Health Care Workers Who Received SARS-CoV-2 Vaccinations
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Humoral Immune Response in Hematooncological Patients and Health Care Workers Who Received SARS-CoV-2 Vaccinations
Authors
Keywords
-
Journal
JAMA Oncology
Volume 8, Issue 1, Pages 106
Publisher
American Medical Association (AMA)
Online
2021-10-01
DOI
10.1001/jamaoncol.2021.5437
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluating the longitudinal effectiveness of preventive measures against COVID-19 and seroprevalence of IgG antibodies to SARS-CoV-2 in cancer outpatients and healthcare workers
- (2021) Dominic Fong et al. WIENER KLINISCHE WOCHENSCHRIFT
- Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients
- (2021) R. Palich et al. ANNALS OF ONCOLOGY
- Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia
- (2021) Yair Herishanu et al. BLOOD
- Low Neutralizing Antibody Responses Against SARS-CoV-2 in Elderly Myeloma Patients After the First BNT162b2 Vaccine Dose
- (2021) Evangelos Terpos et al. BLOOD
- Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients
- (2021) Brian J. Boyarsky et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
- (2021) Brian J. Boyarsky et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
- (2021) Leticia Monin et al. LANCET ONCOLOGY
- Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study
- (2021) Santiago Romero-Brufau et al. BMJ-British Medical Journal
- Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma
- (2021) Sarah Bird et al. Lancet Haematology
- SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity
- (2021) Daniel Mrak et al. ANNALS OF THE RHEUMATIC DISEASES
- High levels of anti–SARS-CoV-2 IgG antibodies in previously infected patients with cancer after a single dose of BNT 162b2 vaccine
- (2021) Dominic Fong et al. EUROPEAN JOURNAL OF CANCER
- Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer
- (2021) Amir Massarweh et al. JAMA Oncology
- Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays
- (2021) Thomas Perkmann et al. Microbiology Spectrum
- Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients
- (2021) Abi Vijenthira et al. Blood Advances
- Managing cancer patients during the COVID-19 pandemic: An ESMO Interdisciplinary Expert Consensus
- (2020) G. Curigliano et al. ANNALS OF ONCOLOGY
- Determinants of COVID-19 disease severity in patients with cancer
- (2020) Elizabeth V. Robilotti et al. NATURE MEDICINE
- Infection rate and clinical management of cancer patients during the COVID-19 pandemic: experience from a tertiary care hospital in northern Italy
- (2020) Dominic Fong et al. ESMO Open
- Risk factors for COVID-19 severity and mortality among solid cancer patients and its impact on anticancer treatment: a nationwide cohort study (GCO-002 CACOVID-19)
- (2020) Astrid Lièvre et al. EUROPEAN JOURNAL OF CANCER
- SARS-CoV-2 Testing in Patients With Cancer Treated at a Tertiary Care Hospital During the COVID-19 Pandemic
- (2020) Anna S. Berghoff et al. JOURNAL OF CLINICAL ONCOLOGY
- SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic
- (2020) Thorsten Fuereder et al. ESMO Open
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Usage Data and Scientific Impact of the Prospectively Established Fluid Bioresources at the Hospital-Based MedUni Wien Biobank
- (2018) Helmuth Haslacher et al. BIOPRESERVATION AND BIOBANKING
- The effect of rituximab on vaccine responses in patients with immune thrombocytopenia
- (2013) I. Nazi et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More